Vindesine in advanced renal cancer. A study of the EORTC genito-urinary tract cancer cooperative group
- 15 April 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (4) , 473-475
- https://doi.org/10.1016/0277-5379(83)90109-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancerEuropean Journal of Cancer and Clinical Oncology, 1982
- Spontaneous regression of metastases of renal cancer: A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literatureCancer, 1981
- Reporting results of cancer treatmentCancer, 1981
- Phase II trial of vindesine in advanced neoplastic diseaseCancer Treatment Reviews, 1980
- Phase I and II studies of vindesineCancer Treatment Reviews, 1980
- Vindesine a short review of preclinical and first clinical dataCancer Chemotherapy and Pharmacology, 1979
- PHASE-II CLINICAL-TRIAL WITH VINDESINE FOR REMISSION INDUCTION IN ACUTE-LEUKEMIA, BLASTIC CRISIS OF CHRONIC MYELOID-LEUKEMIA, LYMPHOSARCOMA, AND HODGKINS-DISEASE - ABSENCE OF CROSS-RESISTANCE WITH VINCRISTINE1978
- Current status of the therapy of advanced renal carcinomaJournal of Surgical Oncology, 1977